Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (211-220 of 355) with videos related to

Pageof 36
Sort By:
Blood|September 6, 2012
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trialKing L Tan, David W Scott, Fangxin Hong, et al.
Leukemia|August 27, 2022
Response to "The WHO classification of haematolymphoid tumours" (Editorial)Steven H Swerdlow, Elias Campo, Daniel A Arber, et al.
British Journal of Haematology|March 16, 2019
Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphomaGreg Hapgood, Susana Ben-Neriah, Anja Mottok, et al.
Haematologica|July 7, 2017
Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assayJean-Philippe Jais, Thierry Jo Molina, Philippe Ruminy, et al.
Leukemia|August 13, 2022
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trialCiara L Freeman, Prasath Pararajalingam, Ling Jin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2013
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopesDaniel J Hui, Etiena Basner-Tschakarjan, Yifeng Chen, et al.
Plos One|April 21, 2016
Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect CorrectionAline Talhouk, Stefan Kommoss, Robertson Mackenzie, et al.
American Journal of Clinical Pathology|April 24, 2012
B cells with high side scatter parameter by flow cytometry correlate with inferior survival in diffuse large B-cell lymphomaAli Bashashati, Nathalie A Johnson, Alireza Hadj Khodabakhshi, et al.
Blood Advances|September 8, 2022
The outcome of older adults with classic Hodgkin lymphoma in British ColumbiaPhoebe T M Cheng, Diego Villa, Alina S Gerrie, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2024
TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphomaMichael Y Li, Lauren C Chong, Gerben Duns, et al.
Pageof 36

Showing results (211-220 of 355) with videos related to

Sort By:
Pageof 36
Blood|September 6, 2012
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trialKing L Tan, David W Scott, Fangxin Hong, et al.
Leukemia|August 27, 2022
Response to "The WHO classification of haematolymphoid tumours" (Editorial)Steven H Swerdlow, Elias Campo, Daniel A Arber, et al.
British Journal of Haematology|March 16, 2019
Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphomaGreg Hapgood, Susana Ben-Neriah, Anja Mottok, et al.
Haematologica|July 7, 2017
Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assayJean-Philippe Jais, Thierry Jo Molina, Philippe Ruminy, et al.
Leukemia|August 13, 2022
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trialCiara L Freeman, Prasath Pararajalingam, Ling Jin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2013
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopesDaniel J Hui, Etiena Basner-Tschakarjan, Yifeng Chen, et al.
Plos One|April 21, 2016
Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect CorrectionAline Talhouk, Stefan Kommoss, Robertson Mackenzie, et al.
American Journal of Clinical Pathology|April 24, 2012
B cells with high side scatter parameter by flow cytometry correlate with inferior survival in diffuse large B-cell lymphomaAli Bashashati, Nathalie A Johnson, Alireza Hadj Khodabakhshi, et al.
Blood Advances|September 8, 2022
The outcome of older adults with classic Hodgkin lymphoma in British ColumbiaPhoebe T M Cheng, Diego Villa, Alina S Gerrie, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2024
TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphomaMichael Y Li, Lauren C Chong, Gerben Duns, et al.
Pageof 36